Literature DB >> 16173800

Tools to analyze protein farnesylation in cells.

Jerry M Troutman1, Michael J Roberts, Douglas A Andres, H Peter Spielmann.   

Abstract

Farnesylation of proteins is catalyzed by protein farnesyl transferase (FTase) and is obligatory for the function of the oncoprotein Ras and a variety of other physiologically important proteins. The rapid and selective detection of cellular protein farnesylation status is crucial to understanding both the function of farnesylated proteins and FTase inhibitors. The unnatural FPP analogue 8-anilinogeranyl diphosphate (AGPP, 3b) is an effective alternative substrate for mammalian FTase. Using antibodies specific for the anilinogeranyl moiety, we show that the alcohol precursor (AGOH, 5b) of AGPP is incorporated into cellular proteins in an FTase dependent manner competitive with endogenous pools of FPP. Continuous treatment of HEK-293 cells with 100 microM AGOH for up to 3 days is neither cytotoxic or cytostatic. Antibodies to detect the unnatural anilinogeranyl group were raised against bovine serum albumin (BSA) and keyhole limpet hemocyanin (KLH) bioconjugates of the activated hapten N-hydroxyphthalimido-succinyl-(S-anilinogeranyl)-L-cysteine methyl ester 9a. Polyclonal antisera containing anti-anilinogeranyl antibodies were generated by immunization of rabbits and a monoclonal anti-anilinogeranyl antibody was raised in mice. ELISA and western blotting of anilinogeranyl modified proteins were used to show the selectivity and measure the titer of the antibodies. The unnatural FPP analogue and corresponding antibodies provide a simple and rapid method for monitoring FTase activity in cells and detection of cellular proteins modified by AGOH 5a.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16173800     DOI: 10.1021/bc050068+

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  29 in total

1.  Analysis of the eukaryotic prenylome by isoprenoid affinity tagging.

Authors:  Uyen T T Nguyen; Zhong Guo; Christine Delon; Yaowen Wu; Celine Deraeve; Benjamin Fränzel; Robin S Bon; Wulf Blankenfeldt; Roger S Goody; Herbert Waldmann; Dirk Wolters; Kirill Alexandrov
Journal:  Nat Chem Biol       Date:  2009-02-15       Impact factor: 15.040

2.  Getting a handle on protein prenylation.

Authors:  James L Hougland; Carol A Fierke
Journal:  Nat Chem Biol       Date:  2009-04       Impact factor: 15.040

3.  Protein farnesyltransferase-catalyzed isoprenoid transfer to peptide depends on lipid size and shape, not hydrophobicity.

Authors:  Thangaiah Subramanian; Suxia Liu; Jerry M Troutman; Douglas A Andres; H Peter Spielmann
Journal:  Chembiochem       Date:  2008-11-24       Impact factor: 3.164

4.  Farnesylation of lamin B1 is important for retention of nuclear chromatin during neuronal migration.

Authors:  Hea-Jin Jung; Chika Nobumori; Chris N Goulbourne; Yiping Tu; John M Lee; Angelica Tatar; Daniel Wu; Yuko Yoshinaga; Pieter J de Jong; Catherine Coffinier; Loren G Fong; Stephen G Young
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

5.  Inhibitors of protein geranylgeranyltransferase-I lead to prelamin A accumulation in cells by inhibiting ZMPSTE24.

Authors:  Sandy Y Chang; Sarah E Hudon-Miller; Shao H Yang; Hea-Jin Jung; John M Lee; Emily Farber; Thangaiah Subramanian; Douglas A Andres; H Peter Spielmann; Christine A Hrycyna; Stephen G Young; Loren G Fong
Journal:  J Lipid Res       Date:  2012-03-23       Impact factor: 5.922

6.  Measurement of protein farnesylation and geranylgeranylation in vitro, in cultured cells and in biopsies, and the effects of prenyl transferase inhibitors.

Authors:  Norbert Berndt; Saïd M Sebti
Journal:  Nat Protoc       Date:  2011-10-27       Impact factor: 13.491

7.  Cdc20 is required for the post-anaphase, KEN-dependent degradation of centromere protein F.

Authors:  Mark D J Gurden; Andrew J Holland; Wouter van Zon; Anthony Tighe; Mailys A Vergnolle; Douglas A Andres; H Peter Spielmann; Marcos Malumbres; Rob M F Wolthuis; Don W Cleveland; Stephen S Taylor
Journal:  J Cell Sci       Date:  2010-01-05       Impact factor: 5.285

8.  Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated.

Authors:  Shao H Yang; Douglas A Andres; H Peter Spielmann; Stephen G Young; Loren G Fong
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

9.  Identification of a farnesol analog as a Ras function inhibitor using both an in vivo Ras activation sensor and a phenotypic screening approach.

Authors:  Kamalakkannan Srinivasan; Thangaiah Subramanian; H Peter Spielmann; Chris Janetopoulos
Journal:  Mol Cell Biochem       Date:  2013-11-06       Impact factor: 3.396

10.  Assessing the efficacy of protein farnesyltransferase inhibitors in mouse models of progeria.

Authors:  Shao H Yang; Sandy Y Chang; Douglas A Andres; H Peter Spielmann; Stephen G Young; Loren G Fong
Journal:  J Lipid Res       Date:  2009-10-26       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.